Results 141 to 150 of about 13,452 (195)

A phase II study of radioimmunotherapy with intraventricular 131I‐3F8 for medulloblastoma

Pediatric Blood & Cancer, 2018
K. Kramer, N. Pandit-Taskar, J. Humm, P. Zanzonico, S. Haque, I. Dunkel, S. Wolden, M. Donzelli, D. Goldman, Jason S. Lewis, S. Lyashchenko, Y. Khakoo, J. Carrasquillo, M. Souweidane, J. Greenfield, D. Lyden, K. D. Braganca, S. Gilheeney, S. Larson, N. Cheung   +19 more
semanticscholar   +1 more source

Radioimmunotherapy: a game-changer for advanced non-small cell lung cancer. [PDF]

Front Immunol
Xue H, Chen Y, Zhou Y.
europepmc   +1 more source

Evidence Mounts for the Efficacy of Radioimmunotherapy for B-Cell Lymphomas [PDF]

, 2008
Oliver W. Press
openalex   +1 more source

Editorial: Understanding biofilms: recent trends and developments. [PDF]

Front Cell Infect Microbiol
Panda SK, da Silva LCN.
europepmc   +1 more source

Targeted Radioimmunotherapy and Theranostics with Alpha Emitters.

Journal of Medical Imaging and Radiation Sciences, 2019
N. Pandit-Taskar
semanticscholar   +1 more source

Advancements and challenges in the treatment of esophageal cancer: A comprehensive review. [PDF]

World J Clin Oncol
Christodoulidis G, Agko SE, Koumarelas KE, Kouliou MN, Zacharoulis D.   +4 more
europepmc   +1 more source

Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes

Journal of Neuro-Oncology, 2019
Kayleen A Bailey, N. Pandit-Taskar, J. Humm, P. Zanzonico, S. Gilheeney, N. Cheung, K. Kramer   +6 more
semanticscholar   +1 more source

RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome. [PDF]

Oncoimmunology
Pol JG, Checcoli A, Lizarralde-Guerrero M, Kroemer G.   +3 more
europepmc   +1 more source

Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry

Molecular Cancer Therapeutics, 2016
J. Houghton, Rosemery Membreno, Dalya Abdel-Atti, K. Cunanan, S. Carlin, W. Scholz, P. Zanzonico, Jason S. Lewis, Brian M. Zeglis   +8 more
semanticscholar   +1 more source

Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging. [PDF]

Eur J Nucl Med Mol Imaging
Altunay B, Morgenroth A, Beheshti M, Vogg A, Wong NCL, Ting HH, Biersack HJ, Stickeler E, Mottaghy FM.   +8 more
europepmc   +1 more source